Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02590237 · ClinicalTrials.gov registry record · NA
KingVision Video Laryngoscopy vs Direct Laryngoscopy - Equivalence Trial
A NA study of Tracheal Intubation, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT02590237: Completed NA study of Tracheal Intubation, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
NCT02590237 is a NA study of Tracheal Intubation that has completed, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 200 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02590237, a NA study of Tracheal Intubation, has completed, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether the Ambu KingVision videolaryngoscope performs as well as direct laryngoscopy for intubating small children and infants.
Primary Outcome
Three timepoints will be recorded, beginning with insertion of the device past the lips into the mouth. These will include time to optimal glottic view, time to removal of device from mouth, and time to first CO2 capnography upstroke. The primary outcome measure will be total time to intubation, as the sum of all three timepoints.
Conditions Studied
Interventions
- DEVICE Ambu KingVision Video Laryngoscope aBlade
- DEVICE Miller Direct Laryngoscopy
Study Locations (1)
Illinois
- Ann & Robert H Lurie Children's Hospital of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2015-10 |
| Est. Completion | 2016-09 |
| Phase | NA |
What the finished NCT02590237 record still lists
NCT02590237 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Tracheal Intubation appearing as the primary indexed condition, and to 2 interventions - of which Ambu KingVision Video Laryngoscope aBlade is the first listed.
NCT02590237 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT02590237 about?
NCT02590237 is a clinical study titled "KingVision Video Laryngoscopy vs Direct Laryngoscopy - Equivalence Trial". The purpose of this study is to determine whether the Ambu KingVision videolaryngoscope performs as well as direct laryngoscopy for intubating small children and infants.
What is the current status of trial NCT02590237?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2015-10. Estimated completion is 2016-09.
What conditions does trial NCT02590237 study?
This clinical trial studies the following conditions: Tracheal Intubation.
What interventions are being tested in trial NCT02590237?
The interventions under investigation include: Ambu KingVision Video Laryngoscope aBlade (DEVICE), Miller Direct Laryngoscopy (DEVICE).
Who is sponsoring clinical trial NCT02590237?
This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02590237 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02590237's enrollment target sits among peer trials
200 506th of 2000 higher than 1,434 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia